Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.
Most participants in clinical trials believe the benefits of broadly sharing individual data outweigh the risks, a new Stanford study has found.
New Stanford Medicine research found that a compound called d-limonene has the potential to help head and neck cancer patients who suffer from dry mouth.
Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.
In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.
A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
Joshua Geller used to be very worried about food. Geller, now 14, has severe food allergies. Until recently, he couldn't safely eat even the tiniest …
When Jeff Schottenstein's wife was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone un-turned in researching potential solutions to …
Should data from clinical trials be available to all? Or just for certain investigations? Who decides? And how would that work? These, and a host …
One in every 200 people in the developed world suffer from an inflammatory autoimmune condition called psoriatic arthritis. For too many of these people, standard …
Clinical trials, in their current incarnation, are ill-suited for the nimble, personalized precision health era, a a panel of speakers at the Big Data in …
Confronted in 2002 by a medical record that was literally two feet in height, Stanford hematologist Jason Gotlib, MD, had no idea that his career path …
I can summarize a recent press release I wrote about an unproven stem cell treatment in three words: sad, shocking and sobering. Three women with …
